Technology | Quality Assurance (QA) | September 12, 2019

IBA Dosimetry Releases myQA Machines Software at ASTRO 2019

New release of myQA Machines enables more efficient radiation therapy machine quality assurance, integrated into the independent global QA platform myQA

IBA Dosimetry Releases myQA Machines Software at ASTRO 2019

September 12, 2019 – IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.

The latest version of the myQA Machines software enables significantly faster execution of all key linear accelerator (linac) quality assurance (QA) tests. It also allows machine QA tests to be performed independently of the linac systems that are being verified.

The new myQA Machines has been designed to ensure QA efficiency through close integration with the treatment machines while maintaining independence from the machines to be tested, to provide the most reliable quality assurance performance.

To enhance workflow efficiency, each of the linac-specific tests of myQA Machines — like the multileaf collimator (MLC) and volumetric modulated arc therapy (VMAT) checks, as well as the 2-D and 3-D imaging QA tests — can now be measured and analyzed easily in a single workflow that is integrated in one dedicated software interface. Test automation further contributes to QA efficiency and avoids human subjectivity during test analysis.

For more information: www.iba-worldwide.com

Related Content

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model)

Image by whitfieldink from Pixabay

News | Radiation Oncology | November 13, 2019
November 13, 2019 — Members of Congress from both sides of the aisle issued a series of oversight letters to the...
Bladder Abdomen Pelvis image with DLCExpert
News | Artificial Intelligence | November 07, 2019
November 7, 2019 — Mirada Medical, a global leader in...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Feature | ASTRO | October 30, 2019 | By Greg Freiherr
At the American Society for Radiation Oncology’s (ASTRO) 2019 a
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost